Skip to main content

Table 3 IR and BMI-based comparison of PCOS patients and controls

From: Plasma level of peroxiredoxin 3 in patients with polycystic ovarian syndrome

 

n

Age

BMI

FPG (mmoL/L)

FINS (mU/L)

HOMA-IR

PRX3 (ng/ml)

Control-IRL -Lean

28

29.6 ± 4.4

20.9 ± 3.3

5.3 ± 0.5

7.7 ± 0.6

1.8 ± 0.1

29.8 ± 3.4

t values

 

0.397

7.534

2.580

7.961

4.962

0.156

P values

 

0.695

< 0.001a

0.02a

< 0.001a

< 0.001a

0.877

PCOS-IRH -Obese

22

29.3 ± 3.0

31.4 ± 3.1

6.7 ± 1.5

29.3 ± 10.5

9.2 ± 5.2

30.4 ± 3.6

t values

 

−1.093

4.315

2.661

6.001

4.646

1.154

P values

 

0.293

0.001a

0.02a

< 0.001a

0.001a

0.268

PCOS-IRL -Lean

10

31 ± 2.6

24.8 ± 2.0

5.3 ± 0.4

9.0 ± 2.6

1.9 ± 0.5

25.1 ± 2.7

  1. asignificant difference